Compounds useful for treating diseases caused by retroviruses

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9827237
APP PUB NO 20160151348A1
SERIAL NO

14902935

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for preventing or treating retroviral infection not HIV and/or for preventing, inhibiting or treating a disease caused by the retroviral infection include contacting a cell with compound (I)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE75016 PARIS
INSTITUT CURIE75248 PARIS CEDEX 05
UNIVERSITÉ DE MONTPELLIER163 RUE AUGUSTE BROUSSONNET MONTPELLIER 34090
ABIVAX75008 PARIS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Campos, Noëlie Le Cres, FR 4 25
Garcel, Aude Le Cres, FR 16 120
Mahuteau-Betzer, Florence Saint Remy-les-Chevreuse, FR 14 58
Najman, Romain l'Hay les Roses, FR 38 193
Scherrer, Didier Castelnau le Lez, FR 46 194
Tazi, Jamal Clapiers, FR 50 248

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 28, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 28, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00